સ્તન કેન્સર
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
ક્યાં જવું
ભારતમાં 1 હોસ્પિટલ આ trial માટે દર્દીઓ લઈ રહી છે.
રજિસ્ટ્રી સમરી (ટેકનિકલ)
This study will evaluate the efficacy and safety of inavolisib in combination with Phesgo (pertuzumab, trastuzumab, and rHuPH20 injection for subcutaneous use) compared with placebo in combination with Phesgo, as maintenance therapy, after induction therapy in participants with previously untreated HER2-positive advanced breast cancer (ABC).
Sponsor: Hoffmann-La Roche
NCT05894239 on ClinicalTrials.gov
છેલ્લે 16 Oct 2026 ના રોજ registry માં update થયું · અમને 20 Oct 2026 ના રોજ વાંચ્યું